Kassem, M. (2019). Renal biomarkers. test, 23(2), 111-116. doi: 10.21608/smj.2019.47651
Mohamed A Kassem. "Renal biomarkers". test, 23, 2, 2019, 111-116. doi: 10.21608/smj.2019.47651
Kassem, M. (2019). 'Renal biomarkers', test, 23(2), pp. 111-116. doi: 10.21608/smj.2019.47651
Kassem, M. Renal biomarkers. test, 2019; 23(2): 111-116. doi: 10.21608/smj.2019.47651

Renal biomarkers

Sohag Medical Journal
Article 23, Volume 23, Issue 2, April 2019, Pages 111-116    PDF (305.31 K)
Document Type: Original Article
DOI: 10.21608/smj.2019.47651
Author
Mohamed A Kassem
Department of Pediatrics, Faculty of Medicine, Sohag University, Sohag, Egypt.
Abstract
 Acute kidney injury is common in critically ill children admitted to the intensive care unit. The etiology of acute kidney injury is multifactorial and the incidence varies between 1 and 41% (Krishnamurthy, 2013) probably due to the different definitions used in clinical studies.
Unfortunately, Serum Creatinine (the main acute kidney injury biomarker used in the clinical setting) is a late marker of reduced glomerular filtration rate, which limits the ability to detect acute kidney injury early and to initiate clinical therapeutic studies. Therefore, Diagnostic specificity and sensitivity of new biomarkers are currently weighed against creatinine-based criteria (Waikar et al., 2009).
 Several proteins and biochemical markers emerged as sensitive and specific biomarkers capable of the early detection of acute tubular injury (Devarajan, 2011). The most famous of these biomarkers is neutrophil gelatinase-associated lipocalin (NGAL).
Keywords
Neutrophil gelatinase-associated lipocalin; Acute kidney injury; creatinine
Supplementary Files
References
  1. Basu R, Zappitelli M, Brunner L, et al. Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int. 2014;85(3):659–667.
  2. Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: A prospective study. Clin J Am Soc Nephrol 2008; 3: 665-73.
  3. Ciccia E, Devarajan P. Pediatric acute kidney injury: prevalence, impact and management challenges. International Journal of Nephrology and Renovascular Disease  2017:10 Pages 77—84.
  4. Dent CL, Ma Q, Dastrala S, Bennett M, Mitsnefes MM, Barasch J, et al. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity, and mortality after pediatric cardiac surgery: A prospective uncontrolled cohort study. Crit Care 2007; 11(6): R127.
  5. Devarajan P. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr. 2011;23(2):194–200.
  6. Devarajan P. Genomic and proteomic characterization of acute kidney injury. Nephron. 2015;131(2):85–91.
  7. Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med. 2010;4(2):265–280.
  8. Devarajan P. Pediatric acute kidney injury: different from acute renal failure but how and why. Curr Pediatr Rep. 2013;1(1):34–40.
  9. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;54(6):1012–1024.
  10. Haase M, Devarajan P, Haase-Fielitz A, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol. 2011;57(17):1752–1761.
  11. Haase-Fielitz A, Haase M, Devarajan P. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status. Ann Clin Biochem. 2014;51(pt 3):335–351.
  12. Han WK, Waikar SS, Johnson A, et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008;73(7):863–869.
  13. Hirsch R, Dent C, Pfriem H, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol. 2007;22(12):2089–2095.
  14. Jefferies JL, Devarajan P. Early detection of acute kidney injury after pediatric cardiac surgery. Prog Pediatr Cardiol. 2016;41:9–16.
  15. Krawczeski CD, Goldstein SL, Woo JG, et al. Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol. 2011;58(22):2301–2309.
  16. Krishnamurthy S. Incidence and etiology of acute kidney injury in Southern India: author’s reply. Indian J Pediatr. 2013; 80: 797.
  17. Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14(10):2534–2543.
  18. Mishra J, Mori K, Ma Q, et al. Amelioration of ischemic acute renal injury by a neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 2004;15(12):3073–3082.
  19. Nickolas TL, O’Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008;148(11):810–819.
  20. Nickolas TL, Schmidt-Ott KM, Canetta P, et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol. 2012;59(3):246–255.
  21. Parikh CR, Devarajan P, Zappitelli M, et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol. 2011;22(9):1737–1747.
  22. Parikh CR, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006;70(1):199–203.
  23. Parikh CR, Thiessen-Philbrook H, Garg AX, et al. Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol. 2013;8(7):1079–1088.
  24. Portilla D, Dent C, Sugaya T, et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2008;73(4):465–472.
  25. Schuh MP, Nehus E, Ma Q, et al. Long-term stability of urinary biomarkers of acute kidney injury in children. Am J Kidney Dis. 2016;67(1):56–61.
  26. Soto K, Papoila AL, Coelho S, et al. Plasma NGAL for the diagnosis of AKI in patients admitted from the emergency department setting. Clin J Am Soc Nephrol. 2013;8(12):2053–2063.
  27. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P. Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 2003;63(5):1714–1724.
  28.   Waikar S, Betensky R, Bonventre J: Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant 2009, 24:3265-3268.
  29. Yang L, Brooks CR, Xiao S, et al. KIM-1-mediated phagocytosis reduces acute injury to the kidney. J Clin Invest. 2015;125(4):1620–1636.
  30. Zhou F, Luo Q, Wang L, Han L. Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis. Eur J Cardiothorac Surg. 2016; 49(3):746–755.
 

 

 

 

 

 

 

Statistics
Article View: 196
PDF Download: 275